News
Spectral AI, Inc. Q1 Overview. Research & Development Revenue of $6.7 Million. Improved Capital Structure Reflected in Cash of $14.1 Million. Continued work on planned De Novo submission to the ...
Tigris Trial Enrollment Reaches 106 Patients Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback